The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
Miplyffa is the first drug approved for treating associated neurological symptoms in adults and children 2 years and older. HealthDay News — The U.S. Food and Drug Administration has approved Miplyffa ...